JPRN-UMIN000012972已完成未知
A phase II study of nab-paclitaxel for pretreated non-small cell lung cancer - A phase II study of nab-paclitaxel for pretreated non-small cell lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients previously treated with paclitaxel derivative drugs 2)Anamnesis of hypersensitivity to albumin 3)pleural effusion(eligible for difficult puncture case or cytologically negative and clinically ignorable case) 4)evident pericardial effusion 5)serious complications below uncontrollable angina pectoris, myocardial infarction within 3 months or heart failure uncontrollable diabetes uncontrollable hypertension severe infection 6)pulmonary fibrosis or interstitial pneumonitis evident 7)HB and HC virus carrier 8)now pregnant or lactation 9)difficult to perform or continue of this study
研究者
相似试验
已完成
2 期
Phase II study of nab-paclitaxel for pretreated NSCLCon-small cell lung cancerJPRN-UMIN000014357Kitasato university hospital, division of respiratory medicine20
已完成
不适用
Phase II Study of nab-paclitaxel in Treated Patients with Advanced Non-Small Cell Lung CancerTreated patients with advanced non-small cell lung cancerJPRN-UMIN000015841Tohoku Medical and Pharmaceutical University30
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
已完成
2 期
Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.urothelial cancerJPRN-UMIN000015260Department of Urology, Saitama Medical Center, Saitama Medical University5
已完成
2 期
Phase 2 study of Nab-Paclitaxel for patients with previously treated EGFR wild-type non-small-cell lung cancer.on-small-cell lung cancerJPRN-UMIN000018233Shimane university hospital45